Research progress of isoquercitrin in the treatment of diabetes and its complications

Diabetes mellitus (DM) is a group of multifactorial metabolic disorders characterized by chronic high blood glucose levels. It is often the result of impaired insulin secretion or insulin resistance.This article discusses the improvement of isoquercitrin on diabetes and its associated complications, including type 2 diabetes, hepatic gluconeogenesis, and diabetic neuropathy. We reviewed the published related papers in detail, analyzed the pathogenesis of diabetes from the perspective of its pathogenesis, and showed how isoquercitrin affects its key signaling pathways by regulating the levels of related factors, and ultimately improves the role of diabetes and its related complications.